drugset / Trial / NCT00402337
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to evaluate the efficacy and safety of administration of linaclotide acetate in patients with chronic constipation.
Timeline
- Start
- 2006-11
- Primary completion
- 2007-12
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linaclotide | Peptide | 72 ug | Oral |
| Comparator | Linaclotide | Peptide | 145 ug | Oral |
| Comparator | Linaclotide | Peptide | 290 ug | Oral |
| Comparator | Linaclotide | Peptide | 579 ug | Oral |